Abi Cone
About Abi Cone
Abi Cone is a Senior Scientist in Analytical Development at Adaptimmune, specializing in bioassay development for lentiviral and genetically engineered T cell characterization. With a background in Biological Sciences, Cone has contributed significantly to analytical development projects since joining Adaptimmune in 2019.
Current Role as Senior Scientist
Currently, Abi Cone serves as a Senior Scientist in Analytical Development at Adaptimmune, a position held since 2019. In this role, Cone focuses on the development and qualification of bioassays that are essential for the characterization of lentiviral and genetically engineered T cells. This work is critical in the field of immunotherapy, contributing to the advancement of bioassay methodologies that support therapeutic applications.
Previous Experience at Adaptimmune
Prior to the current role, Abi Cone worked at Adaptimmune as a Scientist in Phage Display from 2015 to 2018. During this three-year tenure in Abingdon, United Kingdom, Cone contributed to projects that enhanced the understanding and application of phage display technology in the context of immunotherapy. This experience laid the groundwork for subsequent advancements in T cell characterization.
Educational Background in Biological Sciences
Abi Cone completed a BSc in Biological Sciences at the University of Reading from 2006 to 2010. Following this, Cone pursued a PhD in the same field at the same institution, which was completed in 2015. This extensive academic background provided a solid foundation in biological sciences, equipping Cone with the necessary knowledge and skills for a career in scientific research and development.
Research Experience as Doctoral Student
During the period from 2010 to 2015, Abi Cone worked as a Doctoral Student at the University of Reading. This five-year experience involved conducting research that contributed to the field of biological sciences. The insights gained during this time have informed Cone's subsequent work in analytical development and bioassay qualification.
Contributions to Bioassay Development
Abi Cone has been actively involved in analytical development projects that emphasize the characterization of genetically engineered T cells. This work includes the advancement of bioassay development specifically for lentiviral applications, which plays a significant role in the evolving landscape of immunotherapy. Cone's contributions are integral to the ongoing efforts to enhance therapeutic strategies in this area.